DK3129057T3 - Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi - Google Patents

Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi Download PDF

Info

Publication number
DK3129057T3
DK3129057T3 DK15717051.5T DK15717051T DK3129057T3 DK 3129057 T3 DK3129057 T3 DK 3129057T3 DK 15717051 T DK15717051 T DK 15717051T DK 3129057 T3 DK3129057 T3 DK 3129057T3
Authority
DK
Denmark
Prior art keywords
glycolipids
pharmaceutical compositions
therapeutic use
therapeutic
pharmaceutical
Prior art date
Application number
DK15717051.5T
Other languages
English (en)
Inventor
Andrew Bottley
Christopher Hayes
Graham Seymour
Anna Grabawska
Philip Clarke
Original Assignee
Univ Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nottingham filed Critical Univ Nottingham
Application granted granted Critical
Publication of DK3129057T3 publication Critical patent/DK3129057T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK15717051.5T 2014-04-04 2015-04-07 Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi DK3129057T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1406172.5A GB201406172D0 (en) 2014-04-04 2014-04-04 Therapy and pharmaceutical composition
PCT/GB2015/051068 WO2015150839A1 (en) 2014-04-04 2015-04-07 Glycolipids and pharmaceutical compositions thereof for use in therapy

Publications (1)

Publication Number Publication Date
DK3129057T3 true DK3129057T3 (da) 2023-10-02

Family

ID=50776888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15717051.5T DK3129057T3 (da) 2014-04-04 2015-04-07 Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi

Country Status (11)

Country Link
US (2) US10428102B2 (da)
EP (2) EP3129057B1 (da)
CN (2) CN106413753B (da)
AU (3) AU2015242363C1 (da)
CA (2) CA3209430A1 (da)
DK (1) DK3129057T3 (da)
ES (1) ES2958492T3 (da)
GB (1) GB201406172D0 (da)
MX (2) MX392452B (da)
PL (1) PL3129057T3 (da)
WO (1) WO2015150839A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201406172D0 (en) 2014-04-04 2014-05-21 Univ Nottingham Therapy and pharmaceutical composition
EP3658152A1 (en) * 2017-07-28 2020-06-03 The University Of Nottingham Fruit extract and uses thereof
CN111770692A (zh) * 2018-01-23 2020-10-13 中央研究院 昭和草萃取物用于治疗乳癌的用途
GB201903873D0 (en) * 2019-03-21 2019-05-08 Univ Nottingham Enhanced transfection
GB202203181D0 (en) * 2022-03-08 2022-04-20 Aceae Nutra Ltd Inhibitors of elF4A

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668930B1 (fr) * 1990-11-09 1995-02-17 Oreal Composition cosmetique, pharmaceutique ou alimentaire comportant une dispersion aqueuse de vesicules lipidiques.
GB9819384D0 (en) * 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds II
JP2006117582A (ja) 2004-10-21 2006-05-11 Fancl Corp インターロイキン4産生抑制剤とその利用
CN101119965B (zh) * 2004-12-21 2012-09-26 弗·哈夫曼-拉罗切有限公司 萘满和茚满衍生物及其用途
PE20070523A1 (es) * 2005-09-12 2007-06-28 Wyeth Corp Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona
US7547455B2 (en) * 2006-09-20 2009-06-16 Academia Sinica Cancer and inflammatory disorder treatment
EP2349281A1 (en) * 2008-10-30 2011-08-03 Hyben Vital Licens ApS Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
WO2013152299A2 (en) 2012-04-06 2013-10-10 University Of North Carolina At Chapel Hill Inhibitors of eif4a and derivatives of pateamine a with antiviral activity and use
GB201406172D0 (en) 2014-04-04 2014-05-21 Univ Nottingham Therapy and pharmaceutical composition
US9649078B2 (en) 2015-07-28 2017-05-16 Dental Imaging Technologies Corporation Hybrid X-ray system with detachable radiation shield

Also Published As

Publication number Publication date
CN106413753B (zh) 2022-04-12
US20170275323A1 (en) 2017-09-28
EP4285998A3 (en) 2024-02-14
AU2015242363C1 (en) 2022-09-22
US10428102B2 (en) 2019-10-01
GB201406172D0 (en) 2014-05-21
PL3129057T3 (pl) 2023-12-18
AU2020202332B9 (en) 2022-04-07
EP3129057A1 (en) 2017-02-15
MX2016013039A (es) 2017-04-27
EP4285998A2 (en) 2023-12-06
US20190382433A1 (en) 2019-12-19
AU2015242363A1 (en) 2016-11-03
MX2022006003A (es) 2022-06-22
AU2020202332B2 (en) 2022-03-17
CN114685414A (zh) 2022-07-01
US11248016B2 (en) 2022-02-15
ES2958492T3 (es) 2024-02-09
CA3209430A1 (en) 2015-10-08
CA2980885C (en) 2023-10-03
EP4285998B1 (en) 2026-05-06
AU2020202332A1 (en) 2020-04-23
CN114685414B (zh) 2026-02-13
AU2022203774A1 (en) 2022-06-23
MX392452B (es) 2025-03-24
CN106413753A (zh) 2017-02-15
EP3129057B1 (en) 2023-07-05
AU2015242363B2 (en) 2020-01-02
CA2980885A1 (en) 2015-10-08
WO2015150839A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
IL290823A (en) Pharmaceutical compositions for combination therapy
IL258931A (en) Therapeutic compounds and methods
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK3209681T3 (da) Farmaceutiske sammensætninger omfattende peptidvarianter og fremgangsmåder til anvendelse deraf
IL254552A0 (en) Polycyclic carbamoylpyridone compounds and their pharmaceutical uses
SI4070787T1 (sl) Farmacevtske formulacije
EP3476386C0 (en) LIQUID PHARMACEUTICAL COMPOSITION
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
EP3310376A4 (en) MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
DK3233111T3 (da) Farmaceutisk sammensætning, der omfatter plasminogen, og anvendelser deraf
DK3380525T3 (da) Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf
DK3236934T3 (da) Farmaceutisk sammensætning, fremstilling og anvendelser deraf
DK3528787T3 (da) Farmaceutiske formuleringer og fremgangsmåder til fremstilling heraf
DK3431460T3 (da) Ny formulering og fremgangsmåde til syntese
PT3200772T (pt) Composições farmacêuticas compreendendo alpelisib
DK3328368T3 (da) Forbindelser og farmaceutisk sammensætning associeret med ubiquitinering-proteasomsystem
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
DK3383397T3 (da) Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin
DK3229843T3 (da) Farmaceutisk sammensætning, præparat og anvendelser deraf
DK3280447T3 (da) Farmaceutiske formuleringer
DK3240821T3 (da) Lavdosis gashydrathæmmersammensætning og tilhørende fremgangsmåde
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
PL3129057T3 (pl) Glikolipidy i ich kompozycje farmaceutyczne do stosowania w leczeniu